|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
| Loss from operations before income taxes | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Share option charge | |||||
| Warrant charge | |||||
| Forfeiture of options | |||||
| Depreciation of fixed assets | |||||
| (Gain)/Loss on foreign exchange | |||||
| Expenses settled in shares | |||||
| Shares Issued in lieu of consultancy fees | |||||
| Shares Issued in lieu of bonus | |||||
| CLN Fees settled in shares | |||||
| Shares Issued in lieu of interest | |||||
| Convertible loan interest accrued | |||||
| Net increase/(decrease) in related party balances | |||||
| Net (increase)/decrease in operating assets/other receivables | |||||
| Net increase/(decrease) in trade and other payables | |||||
| Cash inflow from taxation | |||||
| Net cash used in operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||
| Short Term Investments | |||||
| Acquisition of property, plant and equipment | |||||
| Net cash used in investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
| Proceeds from Fundraising, net | |||||
| Proceeds from fundraising, net and issuance of ordinary shares | |||||
| Proceeds from convertible loan note | |||||
| Net cash provided by financing activities | |||||
| Net increase/(decrease) in cash and cash equivalents | |||||
| Cash and cash equivalent, beginning of period | |||||
| Exchange difference | |||||
| Cash and cash equivalent, end of period | |||||
| Non Cash items: | |||||
| Conversion of related party loan into shares | |||||
| Conversion of convertible loan note into shares | |||||
| Convertible loan note interest liability settled by the issuance of shares | |||||
Loading...